COVID-19 test offers solution for population-wide testing, scientists say: More than 80,000 tests done in under two months

ScienceDaily | Jul 2, 2021 at 4:32 AM
  • SwabSeq uses sample-specific molecular barcodes to simultaneously analyze thousands of samples for the presence or absence of SARS-CoV-2, the virus that causes COVID-19.
  • SwabSeq was granted FDA Emergency Use Authorization in October and is currently deployed at UCLA in a high-complexity CLIA laboratory.
  • UCLA scientists have been leading a broader coalition of academic and industrial labs around the country and the world to develop the technology to scale up COVID-19 testing.